Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 2
2013 2
2014 1
2016 2
2017 2
2019 4
2020 3
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean brian ross[Author] (369 results)?
Histone Modifications as Biomarkers for Immunotherapy.
Taylor EM, Koss B, Davis LE, Tackett AJ. Taylor EM, et al. Among authors: koss b. Methods Mol Biol. 2020;2055:213-228. doi: 10.1007/978-1-4939-9773-2_10. Methods Mol Biol. 2020. PMID: 31502154 Review.
CAR-T Therapies in Solid Tumors: Opportunities and Challenges.
Guzman G, Reed MR, Bielamowicz K, Koss B, Rodriguez A. Guzman G, et al. Among authors: koss b. Curr Oncol Rep. 2023 May;25(5):479-489. doi: 10.1007/s11912-023-01380-x. Epub 2023 Feb 28. Curr Oncol Rep. 2023. PMID: 36853475 Free PMC article. Review.
Indicators of responsiveness to immune checkpoint inhibitors.
Shields BD, Mahmoud F, Taylor EM, Byrum SD, Sengupta D, Koss B, Baldini G, Ransom S, Cline K, Mackintosh SG, Edmondson RD, Shalin S, Tackett AJ. Shields BD, et al. Among authors: koss b. Sci Rep. 2017 Apr 11;7(1):807. doi: 10.1038/s41598-017-01000-2. Sci Rep. 2017. PMID: 28400597 Free PMC article.
Epigenetic Control of Cdkn2a.Arf Protects Tumor-Infiltrating Lymphocytes from Metabolic Exhaustion.
Koss B, Shields BD, Taylor EM, Storey AJ, Byrum SD, Gies AJ, Washam CL, Choudhury SR, Hyun Ahn J, Uryu H, Williams JB, Krager KJ, Chiang TC, Mackintosh SG, Edmondson RD, Aykin-Burns N, Gajewski TF, Wang GG, Tackett AJ. Koss B, et al. Cancer Res. 2020 Nov 1;80(21):4707-4719. doi: 10.1158/0008-5472.CAN-20-0524. Epub 2020 Oct 1. Cancer Res. 2020. PMID: 33004350 Free PMC article.
Ubiquitin-independent degradation of antiapoptotic MCL-1.
Stewart DP, Koss B, Bathina M, Perciavalle RM, Bisanz K, Opferman JT. Stewart DP, et al. Among authors: koss b. Mol Cell Biol. 2010 Jun;30(12):3099-110. doi: 10.1128/MCB.01266-09. Epub 2010 Apr 12. Mol Cell Biol. 2010. PMID: 20385764 Free PMC article.
Discovery and biological characterization of potent myeloid cell leukemia-1 inhibitors.
Lee T, Bian Z, Zhao B, Hogdal LJ, Sensintaffar JL, Goodwin CM, Belmar J, Shaw S, Tarr JC, Veerasamy N, Matulis SM, Koss B, Fischer MA, Arnold AL, Camper DV, Browning CF, Rossanese OW, Budhraja A, Opferman J, Boise LH, Savona MR, Letai A, Olejniczak ET, Fesik SW. Lee T, et al. Among authors: koss b. FEBS Lett. 2017 Jan;591(1):240-251. doi: 10.1002/1873-3468.12497. Epub 2016 Dec 19. FEBS Lett. 2017. PMID: 27878989 Free PMC article.
22 results